# US 2004/0072305 A1 · Gene expression profiling from FFPE samples

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0072305 A1
- Document ID: US20040072305A1
- Status: Published application
- Kind: A1
- Application number: 10/329,282
- Filed: 2002-12-23
- Published: 2004-04-15
- Earliest claimed: 2002-10-11
- Assignees: Molecular Devices, LLC
- Inventors: Mark G. Erlander; Ranelle C. Salunga
- Web page: https://patentgrep.com/patent/US20040072305A1

## CPC

- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12N 15/1096: {cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR}
- C12Q 1/6809: Methods for determination or identification of nucleic acids involving differential detection
- C12Q 1/6837: using probe arrays or probe chips (C12Q1/6874 takes precedence)
- C12Q 1/6886: for cancer (immunoassay for cancer G01N33/575)
- G16B 25/10: Gene or protein expression profiling; Expression-ratio estimation or normalisation
- C12Q 2600/158: Expression markers
- G16B 25/00: ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

Methods and compositions relating to the generation and use of gene expression data from tissue samples that have been fixed and embedded are provided. The data can electronically stored and implemented as well as used to augment diagnosis and treatment of diseases.

## Claims

### Claim 1

A method of synthesizing cDNA from the polyadenylated RNA from cells of an FFPE sample comprising
a) extracting said RNA from said cells; and
b) contacting said extracted RNA with a primer comprising an oligo dT sequence under conditions that result in the synthesis of a first cDNA strand complementary to said extracted RNA.

### Claim 2 (depends on 1)

The method of claim 1 further comprising heating said RNA extracted from said cells at about 70° C. before contacting said RNA with said primer.

### Claim 3 (depends on 1)

The method of claim 1 wherein said extracting of RNA from said cells comprises
obtaining said cells from said sample;
digesting said cells with proteinase K to produce digested material;
contacted the digested material with a guanidinium containing compound to produce a mixture;
contacting the mixture with a silica matrix to permit RNA binding to the matrix; and
eluting the bound RNA after removal of unbound matter.

### Claim 4 (depends on 2)

The method of claim 2 wherein said heating is for about 3 to about 8 hours.

### Claim 5 (depends on 4)

The method of claim 4 wherein said heating is for about 3 hours.

### Claim 6 (depends on 1)

The method of claim 1 further comprising synthesis of the second cDNA strand by use of random primers.

### Claim 7 (depends on 1)

The method of claim 1 further comprising synthesis of the second cDNA strand in the absence of random primers.

### Claim 8 (depends on 1)

The method of claim 1 wherein said primer is operably linked to a promoter sequence.

### Claim 9 (depends on 6)

The method of claim 6 wherein said random primers are hexamers, heptamers, octamers, or nonamers.

### Claim 10 (depends on 2)

The method of claim 2 wherein said extracting of RNA from said cells comprises
obtaining said cells from said sample;
digesting said cells with proteinase K to produce digested material;
contacted the digested material with a guanidinium containing compound to produce a mixture;
contacting the mixture with a silica matrix to permit RNA binding to the matrix; and
eluting the bound RNA after removal of unbound matter.

### Claim 11 (depends on 10)

The method of claim 10 wherein said heating is for about 3 to about 8 hours.

### Claim 12 (depends on 11)

The method of claim 11 wherein said heating is for about 3 hours.

### Claim 13

A method of diagnosing a patient comprising
obtaining gene expression data from one or more cells of said patient,
comparing said data to a gene expression profile generated by gene expression data from one or more FFPE samples, and
diagnosing said patient as having the disease defined by said gene expression profile.

### Claim 14 (depends on 16)

The method of claim 16 wherein said gene expression profile is generated by amplification of polyadenylated mRNA from said FFPE sample(s).

### Claim 15

A computer readable medium containing a gene expression profile represented as a data structure, said medium having a plurality of data fields stored on the medium and comprising
a first data field representing gene expression profile data that is to be analyzed, said first data field being stored in a range of addresses in said computer readable medium;
one or more receiver objects that will receive test sample expression data for analysis with said gene expression profile data, each receiver object being stored in a separate range of addresses in said computer readable medium,
wherein each receiver object comprises a data field adapted for storing input information for correlation or analysis with said first data field.

### Claim 16 (depends on 15)

The medium of claim 15 wherein said first data field is stored in a range of addresses used by one of said one or more receiver objects.

### Claim 17 (depends on 15)

The medium of claim 15 further comprising a prompt field adapted for storing one or more data prompts to elicit entry of test sample expression data.

### Claim 18 (depends on 15)

The medium of claim 15 wherein said test sample expression data is obtained from cells of a tissue containing sample from a human patient.

### Claim 19 (depends on 15)

The medium of claim 15 wherein said gene expression profile data is derived from amplification of polyadenylated mRNA from one or more FFPE samples.

### Claim 20

A system for correlating gene expression data from an FFPE sample with a disease or treatment outcome experienced by the subject from which said sample was obtained comprising
means for generating said gene expression data by amplification of polyadenylated mRNA from said FFPE sample;
means for identifying one or more gene expression levels correlated with at least one disease or treatment outcome experienced by said subject.
